Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week.
Pieroni M, Moon JC, Arbustini E, Barriales-Villa R, Camporeale A, Vujkovac AC, Elliott PM, Hagege A, Kuusisto J, Linhart A, Nordbeck P, Olivotto I, Pietilä-Effati P, Namdar M. Pieroni M, et al. Among authors: namdar m. J Am Coll Cardiol. 2021 Feb 23;77(7):922-936. doi: 10.1016/j.jacc.2020.12.024. J Am Coll Cardiol. 2021. PMID: 33602475 Free article. Review.
PQ interval in patients with Fabry disease.
Namdar M, Kampmann C, Steffel J, Walder D, Holzmeister J, Lüscher TF, Jenni R, Duru F. Namdar M, et al. Am J Cardiol. 2010 Mar 1;105(5):753-6. doi: 10.1016/j.amjcard.2009.10.056. Am J Cardiol. 2010. PMID: 20185028
Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease.
Namdar M, Steffel J, Jetzer S, Schmied C, Hürlimann D, Camici GG, Bayrak F, Ricciardi D, Rao JY, de Asmundis C, Chierchia GB, Sarkozy A, Lüscher TF, Jenni R, Duru F, Brugada P. Namdar M, et al. Am J Cardiol. 2012 Feb 15;109(4):587-93. doi: 10.1016/j.amjcard.2011.09.052. Epub 2011 Nov 19. Am J Cardiol. 2012. PMID: 22105784
Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis.
Yousef Z, Elliott PM, Cecchi F, Escoubet B, Linhart A, Monserrat L, Namdar M, Weidemann F. Yousef Z, et al. Among authors: namdar m. Eur Heart J. 2013 Mar;34(11):802-8. doi: 10.1093/eurheartj/ehs166. Epub 2012 Jun 26. Eur Heart J. 2013. PMID: 22736678 Free PMC article. No abstract available.
European expert consensus statement on therapeutic goals in Fabry disease.
Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, Fomin VV, Germain DP, Hughes DA, Jovanovic A, Kantola I, Linhart A, Mignani R, Monserrat L, Namdar M, Nowak A, Oliveira JP, Ortiz A, Pieroni M, Spada M, Tylki-Szymańska A, Tøndel C, Viana-Baptista M, Weidemann F, Hilz MJ. Wanner C, et al. Among authors: namdar m. Mol Genet Metab. 2018 Jul;124(3):189-203. doi: 10.1016/j.ymgme.2018.06.004. Epub 2018 Jun 12. Mol Genet Metab. 2018. PMID: 30017653 Review.
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts.
Germain DP, Elliott PM, Falissard B, Fomin VV, Hilz MJ, Jovanovic A, Kantola I, Linhart A, Mignani R, Namdar M, Nowak A, Oliveira JP, Pieroni M, Viana-Baptista M, Wanner C, Spada M. Germain DP, et al. Among authors: namdar m. Mol Genet Metab Rep. 2019 Feb 6;19:100454. doi: 10.1016/j.ymgmr.2019.100454. eCollection 2019 Jun. Mol Genet Metab Rep. 2019. PMID: 30775256 Free PMC article. Review.
The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
Augusto JB, Johner N, Shah D, Nordin S, Knott KD, Rosmini S, Lau C, Alfarih M, Hughes R, Seraphim A, Vijapurapu R, Bhuva A, Lin L, Ojrzyńska N, Geberhiwot T, Captur G, Ramaswami U, Steeds RP, Kozor R, Hughes D, Moon JC, Namdar M. Augusto JB, et al. Among authors: namdar m. Eur Heart J Cardiovasc Imaging. 2021 Jun 22;22(7):790-799. doi: 10.1093/ehjci/jeaa101. Eur Heart J Cardiovasc Imaging. 2021. PMID: 32514567 Free PMC article.
111 results